{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T16:00:22Z","timestamp":1775318422841,"version":"3.50.1"},"reference-count":9,"publisher":"Sociedade Brasileira de Pneumologia e Tisiologia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bras Pneumol."],"DOI":"10.36416\/1806-3756\/e20230405","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T19:19:41Z","timestamp":1718651981000},"page":"e20230405","source":"Crossref","is-referenced-by-count":4,"title":["Clinical remission after biologic therapy discontinuation in pediatric patients with severe asthma: a case series from a tertiary center"],"prefix":"10.36416","author":[{"given":"Giovana","family":"De Marchi Castelli1","sequence":"first","affiliation":[{"name":"1. Universidade Federal de Ci\u00eancias da Sa\u00fade de Porto Alegre \u2013 UFCSPA \u2013 Porto Alegre (RS) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederico","family":"Friederich2","sequence":"additional","affiliation":[{"name":"2. Pontif\u00edcia Universidade Cat\u00f3lica do Rio Grande do Sul \u2013 PUCRS \u2013 Porto Alegre (RS) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anasth\u00e1cia","family":"Ferreira Wiemann2","sequence":"additional","affiliation":[{"name":"2. Pontif\u00edcia Universidade Cat\u00f3lica do Rio Grande do Sul \u2013 PUCRS \u2013 Porto Alegre (RS) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovana","family":"dos Santos2","sequence":"additional","affiliation":[{"name":"2. Pontif\u00edcia Universidade Cat\u00f3lica do Rio Grande do Sul \u2013 PUCRS \u2013 Porto Alegre (RS) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo","family":"M\u00e1rcio Pitrez1","sequence":"additional","affiliation":[{"name":"1. Universidade Federal de Ci\u00eancias da Sa\u00fade de Porto Alegre \u2013 UFCSPA \u2013 Porto Alegre (RS) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22288","published-online":{"date-parts":[[2024,6,17]]},"reference":[{"key":"ref0","unstructured":"1.            Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. Bethesda: GINA; 2022."},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2.            Nieto Garc\u00eda A, Garriga-Baraut T, Plaza Mart\u00edn AM, Nieto Cid M, Torres Borrego J, Folqu\u00e9 Gim\u00e9nez MDM, et al. Omalizumab outcomes for up to 6 years in pediatric patients with severe persistent allergic asthma. Pediatr Allergy Immunol. 2021;32(5):980-991. https:\/\/doi.org\/10.1111\/pai.13484","DOI":"10.1111\/pai.13484"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3.            Normansell R, Walker S, Milan SJ, Walters EH, Nair P. Omalizumab for asthma in adults and children. Cochrane Database Syst Rev. 2014;2014(1):CD003559. https:\/\/doi.org\/10.1002\/14651858.CD003559.pub4","DOI":"10.1002\/14651858.cd003559.pub4"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4.            Menzies-Gow A, Bafadhel M, Busse WW, Casale TB, Kocks JWH, Pavord ID, et al. An expert consensus framework for asthma remission as a treatment goal. J Allergy Clin Immunol. 2020;145(3):757-765. https:\/\/doi.org\/10.1016\/j.jaci.2019.12.006","DOI":"10.1016\/j.jaci.2019.12.006"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5.            Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma [published correction appears in Eur Respir J. 2014 Apr;43(4):1216. Dosage error in article text] [published correction appears in Eur Respir J. 2018 Jul 27;52(1):] [published correction appears in Eur Respir J. 2022 Jun 9;59(6):]. Eur Respir J. 2014;43(2):343-373. https:\/\/doi.org\/10.1183\/09031936.00202013","DOI":"10.1183\/13993003.62020-2013"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6.            Stout JW, Visness CM, Enright P, Lamm C, Shapiro G, Gan VN, et al. Classification of asthma severity in children: the contribution of pulmonary function testing. Arch Pediatr Adolesc Med. 2006;160(8):844-850. https:\/\/doi.org\/10.1001\/archpedi.160.8.844","DOI":"10.1001\/archpedi.160.8.844"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7.            Pitrez PM, de Souza RG, Roncada C, Heinzmann-Filho JP, Santos G, Pinto LA, et al. Impact of omalizumab in children from a middle-income country with severe therapy-resistant asthma: A real-life study. Pediatr Pulmonol. 2017;52(11):1408-1413. https:\/\/doi.org\/10.1002\/ppul.23845","DOI":"10.1002\/ppul.23845"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8.            Deschildre A, Roussel J, Drumez E, Abou-Taam R, Rames C, Le Roux P, et al. Omalizumab discontinuation in children with severe allergic asthma: An observational real-life study. Allergy. 2019;74(5):999-1003. https:\/\/doi.org\/10.1111\/all.13678","DOI":"10.1111\/all.13678"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9.            Arslan B, Pa\u00e7ac\u0131 \u00c7etin G, T\u00fcrk M, G\u00fclmez \u0130, Y\u0131lmaz \u0130. Discontinuing Discontinuing Omalizumab Treatment in Super-Responder Patients with Allergic Severe Asth-ma: Can the Baseline Total IgE Level Be Used as a Biological Marker to Decide Dis-continuing Omalizumab Treatment?. Int Arch Allergy Immunol. 2022;183(10):1071-1077. https:\/\/doi.org\/10.1159\/000525723","DOI":"10.1159\/000525723"}],"container-title":["Jornal Brasileiro de Pneumologia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T19:19:49Z","timestamp":1718651989000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jornaldepneumologia.com.br\/details\/3950\/en-US\/clinical-remission-after-biologic-therapy-discontinuation-in-pediatric-patients-with-severe-asthma--a-case-series-from-a-tertiary-center"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,17]]},"references-count":9,"URL":"https:\/\/doi.org\/10.36416\/1806-3756\/e20230405","relation":{},"ISSN":["1806-3756"],"issn-type":[{"value":"1806-3756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,17]]}}}